ABSENOR

Brand name authorized in: Finland Lithuania Poland

Active ingredients

The drug ABSENOR contains one active pharmaceutical ingredient (API):

1 Valproic acid
UNII 5VOM6GYJ0D - VALPROATE SODIUM

Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.

Read about Valproic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Valproic acid
N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG01

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 007097, 007111, 007134, 106609, 106617, 120535, 469395
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1004788
PL
Rejestru Produktów Leczniczych
Identifier(s): 100168073, 100168989